1. A review of pathophysiology and neuropsychiatric manifestations of COVID-19

   • Madhu Jasti
   • Krishna Nalleballe
   • Sanjeeva Onteddu

   Review 03 June 2020 Pages: 2007 - 2012

   

2. Why do SARS-CoV-2 NSPs rush to the ER?

   • Maryline Santerre
   • Sterling P. Arjona
   • Bassel E. Sawaya

   Review 01 September 2020 Pages: 2013 - 2022

   

3. COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis

   • Vittorio Mantero
   • Lucia Abate
   • Christian Cordano

   Letter to the Editors 25 June 2020 Pages: 2023 - 2025

4. Excess neurological death in New York City after the emergence of COVID-19

   • Adam de Havenon
   • John P. Ney
   • Jennifer J. Majersik

   Letter to the Editors 20 July 2020 Pages: 2026 - 2028

   

5. Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis

   • Vittorio Mantero
   • Damiano Baroncini
   • Christian Cordano

   Letter to the Editors 31 August 2020 Pages: 2029 - 2030

6. Parainfectious encephalitis in COVID-19: “The Claustrum Sign”

   • Frédéric Zuhorn
   • Hassan Omaimen
   • Wolf-Rüdiger Schäbitz

   Letter to the Editors 03 September 2020 Pages: 2031 - 2034

   

7. Bickerstaff encephalitis after COVID-19

   • Lucía Llorente Ayuso
   • Pedro Torres Rubio
   • Fernando Sierra-Hidalgo

   Letter to the Editors 03 September 2020 Pages: 2035 - 2037

   

8. The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland

   • Stella A. Glasmacher
   • Juan Larraz
   • CARE-MND Consortium

   Letter to the Editors 05 September 2020 Pages: 2038 - 2040

   

9. Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in Scotland

   • Stella A. Glasmacher
   • Juan Larraz
   • CARE-MND Consortium

   Correction 20 October 2020 Pages: 2041 - 2041

10. “Smoking paradox” is not true in patients with ischemic stroke: a systematic review and meta-analysis

    • Bo Li
    • Dan Li
    • Ruo-Lan Xiang

    Review Open access 29 October 2019 Pages: 2042 - 2054

    

11. Do heterozygous mutations of Niemann–Pick type C predispose to late-onset neurodegeneration: a review of the literature

    • Susanne A. Schneider
    • Sabina Tahirovic
    • Tatiana Bremova-Ertl

    Review 07 November 2019 Pages: 2055 - 2064

    

12. Genotype–phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients

    • Maryam Erfanian Omidvar
    • Shahram Torkamandi
    • Hamid Ghaedi

    Review 19 November 2019 Pages: 2065 - 2082

    

13. Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window

    • Andrea Cerveró
    • Alfonso Casado
    • Javier Riancho

    Review 02 December 2019 Pages: 2083 - 2089

    

14. Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies

    • Jia Zhang
    • Yanhong Gong
    • Xiaoxv Yin

    Review 02 December 2019 Pages: 2090 - 2098

    

15. The motor prodromes of parkinson’s disease: from bedside observation to large-scale application

    • C. Simonet
    • A. Schrag
    • A. J. Noyce

    Review Open access 04 December 2019 Pages: 2099 - 2108

    

16. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

    • David Adams
    • Yukio Ando
    • Giampaolo Merlini

    Review Open access 06 January 2020 Pages: 2109 - 2122

    

17. Decreased inflammatory cytokine production of antigen-specific CD4⁺ T cells in NMDA receptor encephalitis

    • Le-Minh Dao
    • Marie-Luise Machule
    • Harald Prüss

    Original Communication Open access 13 January 2021 Pages: 2123 - 2131

    

18. Long-term psychosocial outcome following mild traumatic brain injury and minor stroke: a direct longitudinal comparison

    • Daan P. J. Verberne
    • Rudolf W. H. M. Ponds
    • Caroline M. van Heugten

    Original Communication Open access 13 January 2021 Pages: 2132 - 2140

    

19. Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience

    • Maxens Decavèle
    • Aliénor Dreyfus
    • Alexandre Demoule

    Original Communication 16 January 2021 Pages: 2141 - 2150

    

20. Adjunctive steroids in adults with encephalitis: a propensity score analysis

    • Ambreen Allana
    • Mohammed Samannodi
    • Rodrigo Hasbun

    Original Communication 21 January 2021 Pages: 2151 - 2160

    

21. Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis

    • Malin Boremalm
    • Peter Sundström
    • Jonatan Salzer

    Original Communication Open access 21 January 2021 Pages: 2161 - 2168

    

22. Guillain–Barré syndrome in patients treated with immune checkpoint inhibitors

    • Qianqian Fan
    • Yang Hu
    • Bin Zhao

    Original Communication 21 January 2021 Pages: 2169 - 2174

23. KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis

    • Kelly Hares
    • K. Kemp
    • A. Wilkins

    Original Communication Open access 23 January 2021 Pages: 2175 - 2184

    

24. Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients

    • Jenny Stritzelberger
    • Johannes D. Lang
    • Hajo M. Hamer

    Original Communication Open access 23 January 2021 Pages: 2185 - 2191

    

25. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome

    • Sanjiban Chakrabarty
    • Periyasamy Govindaraj
    • Kapaettu Satyamoorthy

    Original Communication Open access 23 January 2021 Pages: 2192 - 2207

    

26. Dystonia in Angelman syndrome: a common, unrecognized clinical finding

    • Edoardo Ferlazzo
    • Michele Ascoli
    • Umberto Aguglia

    Original Communication 23 January 2021 Pages: 2208 - 2212

    

27. Relationship between the degree of recanalization and functional outcome in acute ischemic stroke is mediated by penumbra salvage volume

    • Gabriel Broocks
    • Hashim Jafarov
    • Uta Hanning

    Original Communication Open access 24 January 2021 Pages: 2213 - 2222

    

28. A compound heterozygous PINK1-associated juvenile Parkinson’s disease with pregnancy in Chinese

    • Jun-ying Li
    • Nan-nan Li
    • Rong Peng

    Original Communication 25 January 2021 Pages: 2223 - 2227

    

29. Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing

    • Giulia Seghezzo
    • Yvonne Van Hoecke
    • Valentina Gallo

    Original Communication Open access 26 January 2021 Pages: 2228 - 2237

    

30. Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis

    • Matteo Lucchini
    • Luca Prosperini
    • Massimiliano Mirabella

    Original Communication Open access 26 January 2021 Pages: 2238 - 2245

    

31. Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia

    • Koji Fujita
    • Shichun Peng
    • Vijay Dhawan

    Original Communication 27 January 2021 Pages: 2246 - 2255

    

32. Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia

    • Carlos Toledano-Illán
    • Inés Esparragosa Vázquez
    • Mario Riverol Fernández

    Letter to the Editors 26 February 2021 Pages: 2256 - 2258

    

33. Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis

    • Hans Thomas Hölzer
    • Felix Boschann
    • Victoria Tüngler

    Letter to the Editors Open access 09 March 2021 Pages: 2259 - 2262

    

34. Optic disc edema as a sole manifestation of anti-GQ1b antibody syndrome

    • Seong-Hwan Kim
    • Seol-Hee Baek
    • Ji-Soo Kim

    Letter to the Editors 14 March 2021 Pages: 2263 - 2266

    

35. Vestibular paroxysmia associated with typewriter tinnitus: a case report and literature review

    • Yu Jin Koo
    • Hyo-Jung Kim
    • Ji-Soo Kim

    Letter to the Editors 21 March 2021 Pages: 2267 - 2272

    

36. Do anti-CGRP drugs have a role in migraine aura therapy?

    • Eleonora Matteo
    • Umberto Pensato
    • Sabina Cevoli

    Letter to the Editors 15 April 2021 Pages: 2273 - 2274

37. The sleep and circadian problems of Huntington’s disease: when, why and their importance

    • Z. Voysey
    • S. V. Fazal
    • R. A. Barker

    Neurological Update Open access 23 December 2020 Pages: 2275 - 2283

38. Neurological update: use of cardiac troponin in patients with stroke

    • Jan F. Scheitz
    • Helena Stengl
    • Matthias Endres

    Neurological Update Open access 29 December 2020 Pages: 2284 - 2292

    

39. Correction to: Neurological update: use of cardiac troponin in patients with stroke

    • Jan F. Scheitz
    • Helena Stengl
    • Matthias Endres

    Correction Open access 25 February 2021 Pages: 2293 - 2293

40. Managing blood pressure in acute cerebral infarction

    • M. D. Edwards
    • T. A. T. Hughes

    Journal club 31 May 2021 Pages: 2294 - 2296

41. Eliazar de Wind (1916–1987)

    • Jarosław Sak
    • Magdalena Suchodolska

    Pioneers in Neurology Open access 23 May 2020 Pages: 2297 - 2298

    

42. Sigmund Freud (1856–1939)

    • Andrzej Grzybowski
    • Joanna Żołnierz

    Pioneers in Neurology Open access 08 June 2020 Pages: 2299 - 2300

    

43. Claude Bernard (1813–1878)

    • Bruno Kusznir Vitturi
    • Wilson Luiz Sanvito

    Pioneers in Neurology 20 July 2020 Pages: 2301 - 2303

    

44. Ludwik Maurycy Hirschfeld (1814–1876)

    • Ignacy Gonkowski
    • Slawomir Gonkowski
    • Krystyna Makowska

    Pioneers in Neurology Open access 29 July 2020 Pages: 2304 - 2306